Alison Duffy

479 total citations
25 papers, 338 citations indexed

About

Alison Duffy is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Alison Duffy has authored 25 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 7 papers in Oncology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alison Duffy's work include Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (5 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Alison Duffy is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (5 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Alison Duffy collaborates with scholars based in United States. Alison Duffy's co-authors include Ashkan Emadi, Edward A. Sausville, Naama Schwartz, Maria R. Baer, Géraldine Hall, Stephen J. Greene, Jose L. Nabut, Kristine L. Keller, Miguel Franquiz and Vu H. Duong and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Clinical Medicine.

In The Last Decade

Alison Duffy

23 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Duffy United States 10 98 94 65 63 48 25 338
Justin Arnall United States 12 25 0.3× 64 0.7× 30 0.5× 75 1.2× 10 0.2× 46 333
Welch United States 7 43 0.4× 55 0.6× 90 1.4× 104 1.7× 8 0.2× 13 530
Jill Bates United States 11 15 0.2× 66 0.7× 75 1.2× 75 1.2× 10 0.2× 30 363
Khaldoon Aljerian Saudi Arabia 10 36 0.4× 51 0.5× 24 0.4× 41 0.7× 6 0.1× 50 298
Amar A. Desai United States 11 65 0.7× 84 0.9× 45 0.7× 18 0.3× 96 2.0× 13 442
Muzaffer Çakmak Türkiye 13 59 0.6× 88 0.9× 14 0.2× 74 1.2× 69 1.4× 30 457
Meghan McDonald Canada 7 35 0.4× 173 1.8× 37 0.6× 41 0.7× 7 0.1× 13 878
Mya Thein United States 7 31 0.3× 103 1.1× 57 0.9× 141 2.2× 23 0.5× 13 450
Matthew Howse United Kingdom 7 21 0.2× 54 0.6× 79 1.2× 12 0.2× 125 2.6× 18 313
Ana Hidalgo‐Simon Netherlands 9 35 0.4× 24 0.3× 29 0.4× 45 0.7× 10 0.2× 15 355

Countries citing papers authored by Alison Duffy

Since Specialization
Citations

This map shows the geographic impact of Alison Duffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Duffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Duffy more than expected).

Fields of papers citing papers by Alison Duffy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Duffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Duffy. The network helps show where Alison Duffy may publish in the future.

Co-authorship network of co-authors of Alison Duffy

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Duffy. A scholar is included among the top collaborators of Alison Duffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Duffy. Alison Duffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Emadi, Ashkan, et al.. (2023). Impact of pegaspargase dose capping on incidence of pegaspargase-related adverse events in adults. Journal of Oncology Pharmacy Practice. 30(7). 1130–1137.
3.
Holtzman, Noa G., Alison Duffy, Rima Koka, et al.. (2021). Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens. Cancer Chemotherapy and Pharmacology. 87(6). 817–826. 5 indexed citations
4.
5.
Thompson, Allison, et al.. (2019). Student confidence with oncology pharmacy competencies. Currents in Pharmacy Teaching and Learning. 11(11). 1172–1177. 3 indexed citations
6.
Lapidus, Rena G., Brandon Carter‐Cooper, Alison Duffy, et al.. (2019). Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation. Cancer Chemotherapy and Pharmacology. 83(6). 1105–1112. 12 indexed citations
7.
Peters, Nicholas, et al.. (2019). IMMUNOTHERAPY IN THE ELDERLY: AN IRISH STUDY. Journal of Geriatric Oncology. 10(6). S112–S113.
8.
Emadi, Ashkan, et al.. (2019). Real-world experience managing blinatumomab toxicities in adults with relapsed/refractory acute lymphoblastic leukemia. Journal of Oncology Pharmacy Practice. 26(5). 1080–1085. 1 indexed citations
9.
Duffy, Alison, et al.. (2018). Addressing Administration Challenges Associated With Blinatumomab Infusions. Journal of Infusion Nursing. 41(4). 241–246. 9 indexed citations
10.
Duffy, Alison, et al.. (2018). Facilitating Home Hospice Transitions of Care in Oncology: Evaluation of Clinical Pharmacists’ Interventions, Hospice Program Satisfaction, and Patient Representation Rates. American Journal of Hospice and Palliative Medicine®. 35(9). 1181–1187. 10 indexed citations
11.
Duffy, Alison, et al.. (2017). A single center retrospective analysis of a protocol for high-dose methotrexate and leucovorin rescue administration. Journal of Oncology Pharmacy Practice. 25(1). 76–84. 7 indexed citations
12.
13.
Thom, Kerri A., Emily L. Heil, Lindsay Croft, et al.. (2016). Advancing interprofessional patient safety education for medical, nursing, and pharmacy learners during clinical rotations. Journal of Interprofessional Care. 30(6). 819–822. 18 indexed citations
14.
Reddy, Haritha, Alison Duffy, Noa G. Holtzman, & Ashkan Emadi. (2016). The role of β-elimination for the clinical activity of hypomethylating agents and cyclophosphamide analogues.. PubMed. 3(1). 1–8. 3 indexed citations
15.
Keller, Kristine L., et al.. (2016). Drug–drug interactions in patients receiving tyrosine kinase inhibitors. Journal of Oncology Pharmacy Practice. 24(2). 110–115. 21 indexed citations
16.
17.
Duffy, Alison, et al.. (2015). Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy. Journal of Oncology Pharmacy Practice. 22(2). 374–377. 4 indexed citations
18.
Duffy, Alison, et al.. (2014). Autophagy modulation: a target for cancer treatment development. Cancer Chemotherapy and Pharmacology. 75(3). 439–447. 115 indexed citations
19.
Gourdin, Theodore Stewart, Bhavana Bhatnagar, Alison Duffy, et al.. (2012). Disease response and survival outcomes in acute myeloid leukemia (AML) patients unfit for chemotherapy treated with 10-day decitabine as initial therapy.. Journal of Clinical Oncology. 30(15_suppl). 6611–6611. 1 indexed citations
20.
Hall, Géraldine, et al.. (2004). New directions in peritoneal dialysis patient training.. PubMed. 31(2). 149–54, 159. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justin Arnall Breakdown of academic impact, for papers by Welch Breakdown of academic impact, for papers by Jill Bates Breakdown of academic impact, for papers by Khaldoon Aljerian Breakdown of academic impact, for papers by Amar A. Desai Breakdown of academic impact, for papers by Muzaffer Çakmak Breakdown of academic impact, for papers by Meghan McDonald Breakdown of academic impact, for papers by Mya Thein Breakdown of academic impact, for papers by Matthew Howse Breakdown of academic impact, for papers by Ana Hidalgo‐Simon
Rankless by CCL
2026